Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin–nicotinamide-induced diabetic rats

Journal of Physiology and Biochemistry

Volumn 72, Issue 2, 2016, Pages 327-336

  Jangale, Nivedita M ^a   Devarshi, Prasad P ^b   Bansode, Sneha B ^c   Kulkarni, Mahesh J ^c   Harsulkar, Abhay M ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b Bharati Vidyapeeth   (India)

^c NATIONAL CHEMICAL LABORATORY   (India)

Author keywords

Diabetes; Fish oil; Flaxseed oil; Glycation; Kidney; Streptozotocin

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; FISH OIL; GLUTATHIONE PEROXIDASE 1; HEME OXYGENASE 1; INTERLEUKIN 6; LINSEED OIL; NICOTINAMIDE; STREPTOZOCIN; TRANSCRIPTION FACTOR RELA; ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; EDIBLE OIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OMEGA 3 FATTY ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVITY; INFLAMMATION; LIPID PEROXIDATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RAT; RENAL PROTECTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DIET THERAPY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KIDNEY; METABOLISM; PATHOLOGY; RANDOMIZATION; WISTAR RAT;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; BIOMARKERS; DIABETES MELLITUS, EXPERIMENTAL; DIETARY FATS, UNSATURATED; FATTY ACIDS, OMEGA-3; FISH OILS; GENE EXPRESSION REGULATION; GLYCOSYLATION END PRODUCTS, ADVANCED; INTERLEUKIN-6; KIDNEY; LINSEED OIL; LIPID PEROXIDATION; MALE; NF-KAPPA B; NIACINAMIDE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS, WISTAR; STREPTOZOCIN;

EID: 84962716469     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-016-0482-8     Document Type: Article

References (35)

1. Alexandraki K, Piperi C, Kalofoutis C et al (2006) Inflammatory process in type 2 diabetes: the role of cytokines. Ann N Y Acad Sci 1084:89–117
2. An WS, Kim HJ, Cho KH, Vaziri ND (2009) ω-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol 297:895–903
3. Anitha B, Sampathkumar R, Balasubramanyam M, Rema M (2008) Advanced glycation index and its association with severity of diabetic retinopathy in type 2 diabetic subjects. J Diabetes Complications 22:261–266
4. Baggio B, Musacchio E, Priante G (2005) Polyunsaturated fatty acids and renal fibrosis: pathophysiologic link and potential clinical implications. J Nephrol 18:362–367
5. Bansode SB, Chougale AD, Joshi RS et al (2013) Proteomic analysis of protease resistant proteins in the diabetic rat kidney. Mol Cell Proteomics 12:228–236
6. Barcelli UO, Weiss M, Beach D et al (1990) High linoleic acid diets ameliorate diabetic nephropathy in rats. Am J Kidney Dis 16:244–251
7. Dalla Vestra M, Mussap M, Gallina P et al (2005) Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol 16(Suppl 1):S78–S82
8. Donadio JV Jr, Grande JP, Bergstralh EJ et al (1999) The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J Am Soc Nephrol 10:1772–1777
9. Hagiwara S, Makita Y, Gu L et al (2006) Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. Nephrol Dial Transplant 21:605–615
10. Haliga R, Mocanu V, Păduraru I et al (2009) Effects of dietary flaxseed supplementation on renal oxidative stress in experimental diabetes. Rev Med Chir Soc Med Nat Iasi 113:1200–1204
11. Hayashi K, Haneda M, Koya D et al (2001) Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res Clin Pract 52:85–96
12. Inagi R, Yamamoto Y, Nangaku M et al (2006) A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes 55:356–366
13. Ishii N, Patel KP, Lane PH et al (2001) Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 12:1630–1639
14. Jangale NM, Devarshi PP, Dubal AA et al (2013) Dietary flaxseed oil and fish oil modulates expression of antioxidant and inflammatory genes with alleviation of protein glycation status and inflammation in liver of streptozotocin–nicotinamide induced diabetic rats. Food Chem 141:187–195
15. Kanwar YS, Wada J, Sun L et al (2008) Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood) 233:4–11
16. Kiuchi K, Nejima J, Takano T et al (2001) Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 85:87–91
17. Koya D, Hayashi K, Kitada M et al (2003) Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14(Suppl 3):S250–S253
18. Lauretani F, Semba RD, Bandinelli S et al (2008) Plasma polyunsaturated fatty acids and the decline of renal function. Clin Chem 54:475–481
19. Luo ZF, Qi W, Feng B et al (2011) Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome. Life Sci 88:512–520
20. Makni M, Sefi M, Fetoui H et al (2010) Flax and Pumpkin seeds mixture ameliorates diabetic nephropathy in rats. Food Chem Toxicol 48:2407–2412
21. Nimbalkar VV, Mandlik RV, Naik SR, Maseeh A (2012) Nonenzymatic glycosylation: A biochemical link between chronic hyperglycemia and pathophysiologic processes associated with diabetic complications and aging related debilities. Biomed Aging Pathol 2:133–142
22. Packham DK, Alves TP, Dwyer JP et al (2012) Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Am J Kidney Dis 59:75–83
23. Rashid K, Sinha K, Sil PC (2013) An update on oxidative stress-mediated organ pathophysiology. Food Chem Toxicol 62:584–600
24. Schmid H, Boucherot A, Yasuda Y et al (2006) European cDNA Bank (ERCB) Consortium: modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55:2993–3003
25. Schmidt AM, Yan SD, Yan SF, Stern DM (2001) The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 108:949–955
26. Shimizu H, Ohtani K, Tanaka Y et al (1995) Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients. Diabetes Res Clin Pract 28:35–40
27. Srinivasan S, Pari L (2012) Ameliorative effect of diosmin, a citrus flavonoid against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Chem Biol Interact 195:43–51
28. Stanton RC (2011) Oxidative stress and diabetic kidney disease. Curr Diab Rep 11:330–336
29. Szkudelski T (2012) Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model. Exp Biol Med (Maywood) 237:481–490
30. Tóbon-Velasco JC, Cuevas E, Torres-Ramos MA (2014) Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets 13:1615–1626
31. Velasquez MT, Bhathena SJ, Ranich T et al (2003) Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Kidney Int 64:2100–2107
32. Wendt T, Tanji N, Guo J et al (2003) Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. J Am Soc Nephrol 14:1383–1395
33. Yamamoto Y, Yamagishi S, Yonekura H et al (2000) Roles of the AGE-RAGE system in vascular injury in diabetes. Ann N Y Acad Sci 902:163–172
34. Zhang M, Hagiwara S, Matsumoto M et al (2006) Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: involvement of anti-inflammation and antioxidative stress. Metabolism 55:1590–1598
35. Zirun W (2009) Pathogenesis of diabetic nephropathy. Mod J Integr Tradit Chin West Med 18:2349–2350